1. Home
  2. GPRE vs AURA Comparison

GPRE vs AURA Comparison

Compare GPRE & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

HOLD

Current Price

$16.57

Market Cap

812.2M

Sector

Industrials

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.19

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRE
AURA
Founded
2004
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.2M
713.4M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
GPRE
AURA
Price
$16.57
$7.19
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$12.57
$20.00
AVG Volume (30 Days)
1.2M
565.4K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$2,091,680,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.85
N/A
P/E Ratio
$40.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.08
$4.73
52 Week High
$19.65
$9.54

Technical Indicators

Market Signals
Indicator
GPRE
AURA
Relative Strength Index (RSI) 50.04 53.80
Support Level $14.01 $7.13
Resistance Level $19.29 $7.83
Average True Range (ATR) 0.93 0.34
MACD -0.04 0.02
Stochastic Oscillator 19.95 75.61

Price Performance

Historical Comparison
GPRE
AURA

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: